Stryker | SYK - Nettoeinkommen

Aktienkurs
315.13
Täglich Wechseln
0 0%
Monatlich
-4.10%
Jährlich
-15.74%
Q2 Prognose
320.50




Nettoeinkommen Veränderung Datum
Abbott USD 1.08B 699M 2026-03
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -15M 1.11B 2026-03
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 1.34B 669M 2026-03
CONMED USD 13.83M 2.91M 2026-03
Cooper Companies USD 130.8M 46.2M 2025-12
Danaher USD 1.03B 168M 2026-03
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 38.01M 10.25M 2025-12
Olympus JPY 14.17B 6.03B 2025-12
Smith & Nephew USD 293M 79M 2025-12
Steris USD 192.9M 1000K 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Terumo JPY 32.65B 2.4B 2025-12
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03